Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT01558856
Eligibility Criteria:
Inclusion Criteria:
* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 1 month of follow-up
* The patient understands and reads French
* The patient has symptoms of overactive bladder resistant to first-line treatments (physiotherapy, anticholinergics)
* The patient suffers from an overactive bladder confirmed by a urodynamic panel
* The patient suffers from an overactive bladder unassociated with bladder obstruction as confirmed by flowmetry
* The patient has primary (idiopathic) overactive bladder primary with normal urinalysis, abdominal and pelvic ultrasound, urine cytology + / - cystoscopy
* The patient has no bleeding disorders, or the disorder is properly controlled after treatment
Exclusion Criteria:
* The patient is participating in another study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient refuses to sign the consent
* It is impossible to correctly inform the patient
* The patient is pregnant, parturient, or breastfeeding
* Overactive bladder associated with bladder obstruction as determined by flowmetry
* Overactive bladder unconfirmed by urodynamic panel
* Overactive bladder secondary to another condition:
* vesical: urolithiasis, bladder polyp, interstitial cystitis
* pelivienne: tumor or inflammatory
* neurological: multiple sclerosis, brain tumor, epilepsy
* the patient has an uncorrectable bleeding disorder
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01558856
Study Brief:
Protocol Section:
NCT01558856